Triton Partners acquires 10% Evotec stake ahead off potential takeover
Shares of Germany’s Evotec SE rose by up to 16.2% on Monday after news that private equity firm Triton Partners has acquired a substantial stake in the drug discovery and development specialist ahead of a potential takeover bid for the company, according to a report by Bloomberg.

